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Purpose: To map health outcome related variables from a national register, not part of any validated instrument,
with EQ-5D weights among stroke patients.
Methods: We used two cross-sectional data sets including patient characteristics, outcome variables and EQ-5D
weights from the national Swedish stroke register. Three regression techniques were used on the estimation set
(n = 272): ordinary least squares (OLS), Tobit, and censored least absolute deviation (CLAD). The regression
coefficients for “dressing“, “toileting“, “mobility”, “mood”, “general health” and “proxy-responders” were applied to
the validation set (n = 272), and the performance was analysed with mean absolute error (MAE) and mean square
error (MSE).
Results: The number of statistically significant coefficients varied by model, but all models generated consistent
coefficients in terms of sign. Mean utility was underestimated in all models (least in OLS) and with lower variation
(least in OLS) compared to the observed. The maximum attainable EQ-5D weight ranged from 0.90 (OLS) to 1.00
(Tobit and CLAD). Health states with utility weights <0.5 had greater errors than those with weights ≥0.5 (P < 0.01).
Conclusion: This study indicates that it is possible to map non-validated health outcome measures from a stroke
register into preference-based utilities to study the development of stroke care over time, and to compare with
other conditions in terms of utility.
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Stroke can be both a physically and mentally debilitating
condition. This has implications on the intangible cost
to the patient and care-givers in terms of substantially
reduced health related quality of life (HRQoL) [1]. The
development of stroke care is therefore important in
order to alleviate some of this burden. As a means to
such continuous quality improvement, national registers
for acute stroke have been set up in several countries
[2]. Data collection in these registers may include finan-
cial, clinical, process, and outcome indicators. The out-
come indicators may include survival, satisfaction with
health care services, and different patient related out-
comes such as activities of daily living and HRQoL.
However, none of these outcome variables is suitable
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distribution, and reproduction in any mediumconditions unless it shares a common denominator for
outcome evaluation. For example, mortality is an im-
portant indicator in stroke care but is of less importance
for chronic conditions with low excess mortality. Ge-
neric preference-based measures of the HRQoL are
today more or less common standards for such a com-
mon denominator. The advantage with these measures
is that they reveal an individual’s preferences for one
health state over another and therefore provide a car-
dinal scale (0.8 is better than 0.6). They are constructed
from defined health states and tariffs for conversion into
a single summary index. Tariffs are often elicited from
the general population by trade-offs in risk or time, in
contrast to rating scales such as the visual analogue
scale (VAS). Based on the patient’s reported health pro-
file the tariff is applied to obtain utility values, often
bounded between 0 (death) and 1 (full health). The re-
vealed valuation for a health state is said to represent
the utility weight, which in turn is used to estimate thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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times the life years (or survival) in that health state [3].
The outcomes from an investment in stroke care can
then be evaluated against other alternative investments
that affect health in the society. The most common in-
struments are EQ-5D [4], Short Form 6D (SF-6D), the
latter derived from the generic health profiles SF-12 or
SF-36 [5,6], Health Utilities Index Mark 3 (HUI3) [7],
Quality of Well-Being scale (QWB) [8], and Assessment
of Quality of Life (AQoL) [9]. However, few registries
have included any preference-based HRQoL instrument.
The Australian Stroke Clinical Registry and Riks-Stroke
(RS), the Swedish Stroke register, have used the EQ-5D at
least occasionally in their 3-month follow-up question-
naires [2,10]. A potential solution to this lack of generic
preference-based measures could be a method called
“mapping” or “cross walking” which has gained interest
during the last decade [11-13]. In short, this technique is
based on estimating the relationship between preference-
based and descriptive measures through regression-based
transformations, called “transfer to utility” [14]. This has
also been done for stroke, but it is limited to validated
functional or dependence status and non-preference based
generic HRQoL instruments [13-17].
The purpose of this study was to explore the possibi-
lity to develop an algorithm which estimates the correl-
ation between the EQ-5D and some outcome measures
relevant for stroke and stroke registers, not restricted to
validated instruments. If successful, it would give an in-
dication of the usability of the mapping methodology
where no validated HRQoL instruments are available.
The same methodology could then be applied to other
stroke registers as well. It would also enable the transla-
tion of historical registry data into EQ-5D weights,
allowing for analyses of previous stroke care develop-
ments in terms of QALY gains or losses.
Method
Data
Patient level data was taken from Riks-Stroke, a national
quality register for acute stroke in Sweden. It was
established in 1994 to improve and to ascertain a uni-
form quality of care across geographic areas in Sweden.
It covers all of Sweden’s 78 hospitals that admit patients
with acute stroke, and validations have shown that at
least 85% of all hospital admissions for acute stroke are
included in the register [2]. Data collection in RS in-
cludes patient characteristics, patient living conditions,
process- and outcome variables. Data is collected during
the acute phase of the stroke and at a 3-month follow-
up by questionnaire, which includes patient-reported
outcomes and rehabilitation after stroke. Case record
forms are available on the RS website www.riks-stroke.
org. Patient benefits are measured in terms of survival,activities of daily living (ADL) dependency and living
conditions, satisfaction with health care, low mood and
general health.
We used two cross-sectional RS data sets from two dif-
ferent periods with patients who had experienced their
first haemorrhagic or ischaemic stroke (ICD10: I61, I63
and I64) at age 18 or above. The first data set was origin-
ally collected by Lindgren et al. in 2006 for estimating util-
ity loss and indirect costs after stroke at six centres [18].
They analysed utilities at 3, 6, 9, and 12 months after the
first stroke among patients aged 18 to 75. However, the
data collection did not have an upper age limit, and there-
fore we were able to retrieve 130 patients who responded
to the 3-month follow-up questionnaire, i.e. an additional
73 patients compared with the 57 observations analysed
in their study.
In April through December 2009 we performed an add-
itional data collection among 772 consecutively recruited
patients at 65 hospitals at three months after the index
event (ethical approval: Dnr 95-023, Umeå, Sweden). The
data collection procedure was the same as in 2006. The
aim was to have complete data from both EQ-5D and RS
questionnaires for 400 patients. This would leave us with
more than 500 observations in total, which we deemed
reasonable on the basis of a review by Mortimer et al.
where the median sample size was around 500 [11]. The
two data sets were pooled to provide two randomly split
samples – one for model estimation and one for model
validation. Patients with incomplete, or lacking, EQ-5D
index data were excluded.
Both data sets consisted of RS’s regular acute phase and
3-month follow-up questionnaires. Data from the acute
phase included age, sex, haemorrhagic or ischemic stroke,
risk factors, admission to a stroke unit (i.e. a specialised
stroke team with dedicated premises), stroke severity at
hospital admission (according to the Reaction Level Scale
-85 (RLS) ranging from fully conscious to coma [19]),
amongst others. The follow-up questionnaire captured in-
formation on the patients’ living arrangement, personal
ADL (activities in daily living; mobility, toileting, dressing),
cognitive and communicative problems (speech, reading,
writing), swallowing problems, self-reported depression,
perceived general health, and satisfaction with the care
given. For patients unable to respond themselves, care
givers were asked to complete the questionnaire on behalf
of the patients and information on proxy response was
included.
In addition, the EQ-5D visual analogue scale (VAS) has
been included in the RS 3-month follow-up questionnaire
since 2007, whereas the EQ-5D index was occasionally
used in years 2006 and 2009. The EQ-5D has five dimen-
sions to capture the HRQoL (mobility, self-care, usual ac-
tivities, pain/discomfort, and anxiety/depression), each
with three levels of severity (no problems/some or
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243 unique health states [3]. The UK social tariff [20] was
used to calculate the EQ-5D index in this study.
Selection of mapping variables
In order to identify variables in the RS questionnaire
that would be appropriate to map with, we excluded all
variables related to health care resource in order to
avoid geographical and temporal differences in health
care resources, e.g. access to stroke unit, rehabilitation
and institutional living, etc. The few variables in the RS
questionnaire that were conceptually equivalent to the
domains of the EQ-5D index questionnaire were:
 Assistance needed with toilet (yes, no)
 Assistance needed with dressing/undressing (yes, no)
 Restricted mobility (none (reference), indoors but
not outdoors, both)
 General health (very good (reference), fairly good,
fairly bad, very bad)
 Low mood (never (reference), sometimes, often,
always)
These outcome measures represent important dimen-
sions for stroke patients [2]. They cover both objective
functional outcomes and self-assessed health outcomes
after stroke. We also controlled for if the questionnaire
had been answered by a proxy, i.e. a next of kin or health
professional, in order to capture HRQoL variables among
patients with cognitive or communicative problems [21].
Although they may not be as reliable as patient self-
assessment, discarding these responses means that we
would not have any indication on the HRQoL for patients
unable to respond for themselves – maybe the patients
with the greatest need. It has been shown that pain, emo-
tion and social functioning are those domains with the
lowest agreement between proxy and patient, and the
proxy has a tendency to overestimate the impairment. As
long as the bias is consistent in how proxies assess these
domains, we would make the same error for all cohorts
[21]. By including proxy responses we would therefore be
able to study the change in improvement over time at the
group level for patients who had experienced a severe
stroke.
All variables were transformed into dummy variables
with the category corresponding to “no disability” as the
reference. The reference in the proxy variable was if the
patient had answered in writing, with assistance of kin
or health care personnel, per telephone or at a follow-up
visit. Signs of multicollinearity (volatile coefficients and
sign changes) were considered when adding variables
and categories to the model. The correlation matrix of
coefficients and variance inflation factors (VIF) were
analysed [22].Model selection and validation
We used three different regression models to estimate
the association between EQ-5D weights and independ-
ent factors: ordinary least square (OLS), Tobit, and cen-
sored least absolute deviation (CLAD) regressions, the
two latter to account for the ceiling effect at 1. We esti-
mated the OLS parameters using robust standard errors
to adjust for heteroscedacity. This would not affect the
estimated parameter values but the variance, and there-
fore the inference.
However, the OLS has the disadvantage that it does not
capture the ceiling effect at 1 in the EQ-5D weights. This
ceiling effect results in a censored dependent variable, in-
dicating that values higher than a certain threshold were
not measured, which in the case of EQ-5D utilities is 1.
Therefore we also included Tobit and censored least abso-
lute deviation (CLAD) models, which allows for censored
dependent variables and censored the predicted values at
1. However, the Tobit model has been criticised for gener-
ating biased estimates if the assumptions of normality and
homoscedasticity are violated [23]. Although the CLAD
does not rely on these assumptions, it strives to minimise
the absolute deviation of the median, which may not be
entirely relevant for applications where the resulting util-
ities are used for economic evaluations [24].
For prediction accuracy we used the mean absolute
error (MAE), i.e. the mean of the absolute prediction
error between the observed and estimated individual
EQ-5D weights, and mean square error (MSE), the latter
taking into account both the bias and variation of the
error. In addition, we calculated the percentage of indi-
vidual observations for which the AE was <0.05 or <0.10
[12]. All statistical analyses were performed in STATA/
IC 11.2 (StataCorp, College Station, TX, USA).
Results
We obtained 544 observations with complete EQ-5D
index and clinical variable responses at 3 months after the
index event, whereof 105 and 439 were collected in 2006
and 2009, respectively. Statistically significant differences
in means and proportions between the samples (P < 0.05)
were found in age, the proportion of patients admitted to
a stroke unit, ischemic strokes (ICD-10: I63) and proxy re-
sponses, Table 1. These differences were considered sam-
ple selection bias, apart from admission to a stroke unit,
as these units were developed during the period. Re-
sponders to the 2009 sample with complete data (57%)
were three years younger (74 vs. 77), were more frequently
fully awake at admission (RLS1: 90% vs. 80%) and had
fewer recurrent strokes (26% vs. 37%) compared to incom-
plete data or non-responders, all statistically significant at
P < 0.05. Apart from patients with atrial fibrillation, there
was no statistical difference between the estimation and
the validation sets, Table 1.
Table 1 Patient characteristics and differences between the 2006/2009 samples and the pooled estimation/validation
sets










Age 71 13 74 11 0.048 73 12 73 11 0.934
Male sex 55% 0.50 54% 0.50 0.785 52% 0.50 56% 0.50 0.391
RLS 2-8 6% 0.23 10% 0.30 0.199 9% 0.29 9% 0.29 1.000
Stroke unit 45% 0.50 75% 0.43 0.000 69% 0.46 69% 0.46 0.831
Ischemic stroke 80% 0.40 89% 0.32 0.019 87% 0.34 87% 0.34 0.899
Previous stroke 17% 0.38 26% 0.44 0.063 24% 0.43 24% 0.43 0.862
Atrial fibrillation 20% 0.40 26% 0.44 0.234 28% 0.45 21% 0.41 0.048
Diabetes 13% 0.34 19% 0.39 0.211 19% 0.40 16% 0.36 0.283
Hypertension 51% 0.50 58% 0.49 0.219 54% 0.50 60% 0.49 0.150
Smoker 20% 0.40 14% 0.35 0.120 16% 0.37 15% 0.35 0.637
Proxy response 2% 0.14 9% 0.29 0.011 10% 0.29 6% 0.24 0.153
EQ-5D index 0.57 0.42 0.61 0.38 0.258 0.61 0.41 0.60 0.36 0.756
EQ-5D VAS 62 24 66 23 0.104 66 24 64 22 0.492
Note: SD standard deviation, RLS 2-8 sluggish or comatose at hospital admission; VAS visual analogue scale.
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VAS were only 194 and 211 in the estimation and the
validation sets, respectively. Patients generally rated their
utility higher with EQ-5D VAS, and with a lower coeffi-
cient of variation, than with EQ-5D index valued by the
UK preference weights. The lower variation stemmed in
part from the narrower response interval ranging from 0
to 100 with the VAS, whereas the lowest and highest
utility values attainable with 5D using the UK tariff were






Constant 0.902 0.843 0.961 1.
Toilet assistance −0.151 −0.364 0.062 −0
Dressing assistance −0.187 −0.301 −0.072 −0
Indoor mobility only −0.191 −0.266 −0.116 −0
No mobility −0.363 −0.570 −0.156 −0
General health fairly good −0.055 −0.126 0.016 −0
General health fairly bad −0.155 −0.263 −0.046 −0
General health bad −0.246 −0.463 −0.028 −0
Moody sometimes −0.074 −0.131 −0.017 −0
Moody often −0.208 −0.354 −0.062 −0
Moody always −0.327 −0.503 −0.150 −0
Proxy response −0.132 −0.271 0.007 −0
R2 / Pseudo R2 0.724
Note: OLS = ordinary least square; CLAD = censored least absolute deviation; Coef =All three models indicated that many of the selected
variables were important determinants for stroke patients’
perceived utility, Table 2. The parameter estimate for “toi-
let assistance” was not significant in any model. The upper
confidence intervals for the “proxy response” coefficient in
both the OLS and Tobit models were close to zero (the
threshold for statistical significance) whereas in the CLAD
model it was clearly not statistically significant and with a
small parameter value. In addition, the CLAD model indi-






Lower Upper Lower Upper
068 0.970 1.167 1.000 0.997 1.000
.138 −0.325 0.048 −0.179 −0.418 0.061
.218 −0.362 −0.074 −0.247 −0.446 −0.048
.230 −0.344 −0.117 −0.152 −0.240 −0.064
.393 −0.580 −0.206 −0.281 −0.587 0.025
.129 −0.233 −0.024 −0.121 −0.229 −0.014
.233 −0.367 −0.099 −0.237 −0.367 −0.107
.303 −0.529 −0.077 −0.370 −0.651 −0.088
.137 −0.215 −0.060 −0.107 −0.255 0.011
.274 −0.413 −0.134 −0.223 −0.400 −0.045
.387 −0.610 −0.163 −0.471 −0.788 −0.154
.141 −0.280 −0.001 −0.032 −0.266 0.202
0.657 0.486
coefficient; CI = confidence interval.
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variables. As expected, the maximum attainable value dif-
fered between models, i.e. the maximum utility (OLS:
0.90; Tobit: 1.00; CLAD: 1.00). Although all coefficients
were consistent with respect to the sign regardless of the
model specification, there were differences in the size
of the coefficients. Especially the variables concerning
general health were sensitive to the choice of model with
relative differences in coefficients around 50% between
the OLS and CLAD models. The goodness of fit was not
comparable between models due to differences in R2 esti-
mations, but the OLS R2 of 0.72 indicated that 72% of the
variance was captured in the selected variables. Tests
for multicollinearity between coefficients indicated a cor-
relation only between “Toilet assistance” and “No mo-
bility” (0.744) and a VIF of 4.94. Still, we considered
multicollinearity less of a problem as we were mainly in-
terested in fitting a predictive and not a descriptive model.
All three models over-estimated the mean utility,
Table 3. The OLS model generated a mean closest to the
observed mean and had the smallest MAE and MSE.
However, this lower variation in the OLS model came
with an inability to predict the minimum and maximum
values as good as the Tobit and CLAD models. The
range of predicted health states was greatest with the
Tobit model, but it also generated the highest predicted
errors. The CLAD model provided the best predictions
when limiting the error tolerance to 0.05 followed by the
OLS model. When extending the tolerance to <0.10, the
OLS and Tobit models performed best. Note that an ab-
solute error of 0.10 was more than half the mean MAE
(average 0.17 for all three models) but still less than 50%
of the observations (average 43% for all three models),
indicating a long tail of absolute errors.
Figure 1 presents a scatterplot of the observed and
predicted EQ-5D weights of the validation sample esti-
mated with OLS (the other models produced similar
plots). Ideally these observations should be located along
a diagonal line from -0.594 to 1. However, as seen in
Figure 2, the prediction errors formed clusters above
and below the value of 0.5 (P < 0.05 for all models).
Below the value of 0.5, the predictions had higher vari-
ation and overestimated the utility by 0.26 units on aver-
age, whereas the predictions above 0.5 had lower variationTable 3 Validation of models on the validation sample, obser
Model Mean SD Min M
Observed (n = 272) 0.599 0.364 −0.594 1
OLS 0.639 0.287 −0.293 0
Tobit 0.682 0.324 −0.328 1
CLAD 0.659 0.306 −0.300 1
Note: SD standard deviation; MAE mean absolute error; MSE mean square error; AE
least absolute deviation.and neither over- nor underestimated the EQ-5D weights.
In fact, mean error in EQ-5D ranges <0, 0.00 to 0.24, 0.25
to 0.49, 0.50 to 0.74, and 0.75 to 1 were -0.31, -0.19, -0.15,
-0.01 and 0.10, respectively. This would indicate that the
models provide better predictions for better than for
worse health states.
Discussion
We developed an algorithm for translating variables used
for health care quality assessment into utility weights suit-
able for comparing developments in Swedish stroke care
with other medical conditions. Data for 544 patients 3 -
months after their first stroke were split into an estimation
and a validation set for assessing three different statistical
models: OLS, Tobit and CLAD. Several of the mapped
variables were close to the domain questions in the EQ-
5D which could explain the good fit in all the specified
models. The results also indicated that the variable selec-
tion and parameter estimates differed with the model
specification. Each model had its own advantages/disad-
vantages in terms of predicting the EQ-5D index weights,
and all overestimated the mean weight. The OLS provided
a mean closest to the observed (mean error 0.04 QALY)
but had the most compressed variation resulting in an in-
ability to predict minimum and maximum values correctly.
Our results are in line with what Brazier et al. reported
in a recent review of mapping studies [12]. They found
that the mean error in 119 prediction models ranged
from 0.0007 to 0.042 and MAE between 0.0011 and 0.19
(0.167 in our OLS model). It was also reported that most
studies had lower variance in the predicted values than
in the observed and that there was a tendency for pre-
diction errors to be greater at the lower end of the scale
(worse health).
The EQ-5D instrument has been shown to capture
the HRQoL aspects in stroke patients well, especially
for disability and ADL, although not as sensitive as dis-
ease specific instruments [25,26]. However, long-term
effects mainly affect mental dimensions of HRQoL due
to adaptions and coping strategies to physical disability
[15,27-29]. This could indicate that the same algorithms
may not be applicable to samples at other points in time
than 3 months, or for samples with other symptoms
than in our study.ved and predicted EQ-5D weights
ax MAE MSE AE < 0.05 AE < 0.10
.000 n/a n/a n/a n/a
.902 0.167 0.056 21% 44%
.000 0.173 0.061 20% 45%
.000 0.169 0.059 24% 41%
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Observed EQ5D weights
Figure 1 Plot of observed vs. predicted EQ-5D weights (OLS).
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reported by Riks-Stroke, fewer patients in our sample
were admitted to a stroke unit (75% vs. 87%), ischemic
strokes may be slightly overrepresented, more patients
were fully awake at admission (RLS 1; 90% vs. 82%) but
were approximately the same age [30]. However, for the
purpose of this study, full representativeness may not be
that important as we analysed the relationship at an in-
dividual level for predictions at a group level.
We chose to include responses provided by proxies for
patients unable to answer the questionnaires by them-
selves although proxy response reliability is lower [21]. In-
deed, we found that proxies rated the utility lower even
when controlling for mood. We argued, however, that as
long as we would make a consistent error in all cohorts,
this potential bias would be outweighed by the gain from
including patients with greatest needs, e.g. who have expe-
rienced a severe stroke.
We based our regressions on utility weights using the
UK social tariff developed by Dolan in the absence of a
































Figure 2 Plot of EQ-5D prediction errors from OLS-model vs.
observed EQ-5D weights.[20]. A multinominal logistic regression (MLogit) would
estimate the actual index responses, i.e. the health states,
from the explanatory variables and thereby allow for ap-
plying a country specific tariff. In addition, this technique
would eliminate the problem with the ceiling effect at 1
[11]. However, as the data we used is unique to Sweden
we did not consider this specification. In addition, Rivero-
Arias et al. showed that the difference in predicted utility
did not differ very much with OLS predictions when map-
ping mRS to EQ-5D, although the Mlogit provided a bet-
ter fit for worse health states [16]. However, as Mortimer
and Segal point out in a comprehensive review, individual
prediction errors of EQ-5D weights may not present a
problem for group level analysis [11].
Still, it is necessary to reflect on the implications of
the slight under-estimation of the predicted mean, the
lower variability, and the unevenly distributed prediction
errors across the scale. The unevenly distributed predic-
tion errors limit the use of mapped utility to observa-
tions closer to the interval where the regression errors
are smaller, i.e. closer to the mean in our study. In other
words, the overestimation of more severe health states
indicates that the methodology may not be suitable for
subgroup analyses based on severity. Biases may differ
not only depending on the choice of model and which
preference-based measure is mapped, but also between
the conditions modelled [31]. As utilities often are used
in economic evaluations, which analyses incremental
costs in relation to gained utility, the properties of the
denominator can have a great impact on the resulting
incremental cost-utility ratio. In fact, the use of different
mapping models can result in different reimbursement de-
cisions [31,32]. Consequently, utilities estimated through
mapping may have lower ranking among health technol-
ogy assessment agencies [33]. Utility weights derived from
mapping studies should therefore be used with caution
and seen as a second alternative to primary data when
used for cost-utility analyses [12]. Still, the ability to esti-
mate utilities from data captured for other purposes can
provide important information in the lack of primary data,
e.g. assessment of health care development over time or
for sensitivity analysis in economic evaluations. Although
other registries record different variables than included in
our study, the mapping methodology could be a source of
valuable information.
Conclusion
This study indicates that mapping health-related outcome
variables into preference-based utilities can be done with
fairly good precision even though the mapped variables
are not part of any validated instrument. Although the
precision depends on the ability of the mapped variables
to capture the HRQoL domains relevant among stroke pa-
tients, the choice of statistical model, the severity of the
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utility, we believe that the mapping methodology could be
used by other health care quality registers to evaluate the
care development in terms of QALY gains or losses. In
our sample the OLS model produced the best fit for
predicting the utility mean.
Consent
Written informed consent was obtained from the pa-
tients for publication of this report.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
OG participated in the design, data analysis, interpretation of results and
drafted the manuscript. ME participated in the design, provided statistical
input and edits and revisions to the manuscript. E-LG supervised and
participated in the design, interpretation of the results, and provided edits
and revisions to the manuscript. All authors read and approved the final
manuscript.
Acknowledgement
The authors are grateful to Professor Kjell Asplund at Medicincentrum, Umeå
University Hospital, Umeå and Professor Ulf Persson at the Swedish Institute
for Health Institute, Lund for their valuable comments.
We are also thankful for the unconditional financial support provided
through a regional agreement between Umeå University and Västerbotten
County Council on cooperation in the field of Medicine, Odontology and
Health (ALF).
Author details
1Department of Public Health and Clinical Medicine, Umeå University, Umeå,
Sweden. 2Department of Statistics, Umeå University, Umeå, Sweden.
Received: 27 April 2012 Accepted: 12 February 2013
Published: 7 March 2013
References
1. Carod-Artal FJ, Egido JA: Quality of life after stroke: the importance of a
good recovery. Cerebrovasc Dis 2009, 27(Suppl 1):204–214.
2. Asplund K, et al: The Riks-Stroke story: building a sustainable national
register for quality assessment of stroke care. International journal of
stroke: official journal of the International Stroke Society 2011, 6(2):99–108.
3. Weinstein MC, Torrance G, McGuire A: QALYs: the basics. Value in health:
the journal of the International Society for Pharmacoeconomics and Outcomes
Research 2009, 12(Suppl 1):S5–S9.
4. The EuroQol Group: EuroQol–a new facility for the measurement of health-
related quality of life. The EuroQol Group. Health Policy 1990, 16(3):199–208.
5. Brazier J, Roberts J, Deverill M: The estimation of a preference-based
measure of health from the SF-36. J Health Econ 2002, 21(2):271–292.
6. Brazier JE, Roberts J: The estimation of a preference-based measure of
health from the SF-12. Medical care 2004, 42(9):851–859.
7. Feeny D, et al: Multi-attribute health status classification systems. Health
Utilities Index. PharmacoEconomics 1995, 7(6):490–502.
8. Kaplan RM, Anderson JP: A general health policy model: update and
applications. Health Serv Res 1988, 23(2):203–235.
9. Hawthorne G, Richardson J, Osborne R: The Assessment of Quality of Life
(AQoL) instrument: a psychometric measure of health-related quality of
life. Quality of life research: an international journal of quality of life aspects of
treatment, care and rehabilitation 1999, 8(3):209–224.
10. Cadilhac DA, et al: Protocol and pilot data for establishing the Australian
Stroke Clinical Registry. International journal of stroke: official journal of the
International Stroke Society 2010, 5(3):217–226.
11. Mortimer D, Segal L: Comparing the incomparable? A systematic review
of competing techniques for converting descriptive measures of health
status into QALY-weights. Medical decision making: an international journal
of the Society for Medical Decision Making 2008, 28(1):66–89.12. Brazier JE, et al: A review of studies mapping (or cross walking) non-
preference based measures of health to generic preference-based
measures. The European journal of health economics: HEPAC: health
economics in prevention and care 2010, 11(2):215–225.
13. Chuang LH, Kind P: Converting the SF-12 into the EQ-5D: an empirical
comparison of methodologies. PharmacoEconomics 2009, 27(6):491–505.
14. Mortimer D, Segal L, Sturm J: Can we derive an ‘exchange rate’ between
descriptive and preference-based outcome measures for stroke? Results
from the transfer to utility (TTU) technique. Health Qual Life Outcomes
2009, 7:33.
15. Haacke C, et al: Long-term outcome after stroke: evaluating health-
related quality of life using utility measurements. Stroke; a journal of
cerebral circulation 2006, 37(1):193–198.
16. Rivero-Arias O, et al: Mapping the modified Rankin scale (mRS)
measurement into the generic EuroQol (EQ-5D) health outcome. Medical
decision making: an international journal of the Society for Medical Decision
Making 2010, 30(3):341–354.
17. van Exel NJ, Scholte op Reimer WJ, Koopmanschap MA: Assessment of
post-stroke quality of life in cost-effectiveness studies: the usefulness of
the Barthel Index and the EuroQoL-5D. Quality of life research: an
international journal of quality of life aspects of treatment, care and
rehabilitation 2004, 13(2):427–433.
18. Lindgren P, Glader EL, Jonsson B: Utility loss and indirect costs after stroke
in Sweden. Eur J Cardiovasc Prev Rehabil 2008, 15(2):230–233.
19. Starmark JE, Stalhammar D, Holmgren E: The Reaction Level Scale (RLS85).
Manual and guidelines. Acta neurochirurgica 1988, 91(1–2):12–20.
20. Dolan P: Modeling valuations for EuroQol health states. Medical care 1997,
35(11):1095–1108.
21. Oczkowski C, O’Donnell M: Reliability of proxy respondents for patients with
stroke: a systematic review. Journal of stroke and cerebrovascular diseases: the
official journal of National Stroke Association 2010, 19(5):410–416.
22. O’Brien RM: A caution regarding rules of thumb for variance inflation
factors. Qual Quant 2007, 41(5):673–690.
23. Greene W: Econometric Analysis. 3rd edition. Englewood Cliffs, NJ: Prentice-
Hall; 1997.
24. Thompson SG, Barber JA: How should cost data in pragmatic randomised
trials be analysed? BMJ 2000, 320(7243):1197–1200.
25. Pickard AS, Johnson JA, Feeny DH: Responsiveness of generic health-
related quality of life measures in stroke. Quality of life research: an
international journal of quality of life aspects of treatment, care and
rehabilitation 2005, 14(1):207–219.
26. Salter KL, et al: Health-related quality of life after stroke: what are we
measuring? International journal of rehabilitation research. Internationale
Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de
readaptation 2008, 31(2):111–117.
27. Darlington AS, et al: Coping strategies as determinants of quality of life in
stroke patients: a longitudinal study. Cerebrovasc Dis 2007, 23(5–6):401–407.
28. Jonsson AC, et al: Determinants of quality of life in stroke survivors and
their informal caregivers. Stroke; a journal of cerebral circulation 2005,
36(4):803–808.
29. Ronning OM, Stavem K: Determinants of change in quality of life from 1
to 6 months following acute stroke. Cerebrovasc Dis 2008, 25(1–2):67–73.
30. Riks-Stroke: Årsrapport 2009 [Annual report 2009]. Umeå, Sweden; 2010.
Available at http://www.riks-stroke.org/content/analyser/Rapport09.pdf.
Accessed 2013-02-12.
31. Pickard AS, et al: Are decisions using cost-utility analyses robust to choice
of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes
2005, 3:11.
32. Barton GR, et al: Do estimates of cost-utility based on the EQ-5D differ
from those based on the mapping of utility scores? Health Qual Life
Outcomes 2008, 6:51.
33. Lloyd A, et al: Reimbursement agency requirements for health related
quality-of-life data: a case study. Expert Rev Pharmacoecon Outcomes Res
2009, 9(6):527–537.
doi:10.1186/1477-7525-11-34
Cite this article as: Ghatnekar et al.: Mapping health outcome measures
from a stroke registry to EQ-5D weights. Health and Quality of Life
Outcomes 2013 11:34.
